Human T cell leukemia virus type 1 (HTLV-1) has been identified as the etiologic agent of adult T cell leukemia (ATL) and the neurologic disorder, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Extensive studies performed in HAM/TSP patients have demonstrated that neurologic disease associated with HTLV-1 infection is due to a hyperinflammatory disease state induced by the generation of an intense cytotoxic T cell (CTL) response with large numbers of CD8+ CTLs directed against the Taxi 1 -19 peptide indicating that Tax is available for immune recognition by antigen presenting cells (APCs) that likely contributes to the overly robust Tax-specific CTL response observed in HAM/TSP. The HYPOTHESIS guiding the proposed investigations in this competitive renewal application is that biologic and immunologic activities of the HTLV-1 transactivator protein Tax within the nuclear, cytoplasmic, and extracellular compartments lead to functional alterations in secondary target cell populations (including bone marrow progenitor cells, cells of the monocyte-macrophage lineage, APCs such as dendritic cells, macrophages and B cells and astrocytes). Ultimately, this leads to a hyperactive Tax-specific CTL compartment along with perturbation of additional components of the immune system that results in the neurologic deficits observed in HAM/TSP.
The specific aims that will address specific aspects of this general hypothesis are to (1) determine the effects of AP-1, C/EBP, and Sp transcription factor families on Tax-mediated HTLV-1 LTR regulation in selected secondary target cell populations within the context of an integrated LTR and HTLV-1 infectious molecular clone; (2) define DNA-protein interactions involved in basal and Tax-mediated HTLV-1 LTR regulation by AP-1, C/EBP, and Sp factors within the context of chromatin and utilizing real-time kinetic analyses; (3) define the protein-protein interactions in secondary target cell populations that guide nuclear export, cytoplasmic transport, and secretion of HTLV-1 Tax; and (4) examine the impact of extracellular Tax on the biologic, physiologic, and immunologic function of APCs with respect to the induction of a Tax-specific CTL response. The proposed investigations will provide novel information concerning the molecular pathogenesis of HAM/TSP and facilitate the biomedical translational development of therapeutic initiatives to prevent and/or treat HTLV-1-induced neuroinflammatory disease. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA054559-14
Application #
7287419
Study Section
Special Emphasis Panel (ZRG1-AARR-A (95))
Program Officer
Read-Connole, Elizabeth Lee
Project Start
1991-04-01
Project End
2011-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
14
Fiscal Year
2007
Total Cost
$291,300
Indirect Cost
Name
Drexel University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
002604817
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Mulherkar, Ria; Karabudak, Aykan; Ginwala, Rashida et al. (2018) In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection. Vaccine 36:5046-5057
Ginwala, Rashida; Caruso, Breanna; Khan, Zafar K et al. (2017) HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-?c-/- (RAG1-Hu) and BLT Mice. J Neuroimmune Pharmacol 12:504-520
Pustylnikov, Sergey; Dave, Rajnish S; Khan, Zafar K et al. (2016) Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators. AIDS Res Hum Retroviruses 32:93-100
Ginwala, Rashida; McTish, Emily; Raman, Chander et al. (2016) Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions. J Neuroimmune Pharmacol 11:36-47
Sehgal, Mohit; Zeremski, Marija; Talal, Andrew H et al. (2015) IFN-?-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment. J Interferon Cytokine Res 35:698-709
Jain, Pooja; Lavorgna, Alfonso; Sehgal, Mohit et al. (2015) Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB. Retrovirology 12:23
Zhao, Xuesen; Guo, Fang; Comunale, Mary Ann et al. (2015) Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2. Antimicrob Agents Chemother 59:206-16
Sagar, Divya; Masih, Shet; Schell, Todd et al. (2014) In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine. Vaccine 32:3274-84
Jaworski, Elizabeth; Narayanan, Aarthi; Van Duyne, Rachel et al. (2014) Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein. J Biol Chem 289:22284-305
Shirazi, Jasmine; Shah, Sonia; Sagar, Divya et al. (2013) Epigenetics, drugs of abuse, and the retroviral promoter. J Neuroimmune Pharmacol 8:1181-96

Showing the most recent 10 out of 46 publications